Author Archives: Carly Forster

Cardlytics (CDLX) Got Some Bad News

In a report released today, Jason Kreyer from Craig-Hallum downgraded Cardlytics (NASDAQ: CDLX) to Sell, with a price target of $65.00. The company’s shares closed last Wednesday at $70.57. Currently, the analyst consensus on Cardlytics is a Moderate Buy with

Medifast (MED) Got Some Good News

Jefferies analyst Stephanie Wissink upgraded Medifast (NYSE: MED) to Buy today and set a price target of $210.00. The company’s shares closed last Wednesday at $164.45. Medifast has an analyst consensus of Moderate Buy, with a price target consensus of

American Express (AXP) was Downgraded to a Sell Rating at Wells Fargo

American Express (NYSE: AXP) received a Sell rating and a $90.00 price target from Wells Fargo analyst Donald Fandetti today. The company’s shares closed last Tuesday at $97.75. The word on The Street in general, suggests a Hold analyst consensus

Is Crypto Worth the Hype?

Cryptocurrency trading is a new contender in the global financial trading market, but thanks to the explosion in value of Bitcoin a few years ago, the average citizen is aptly aware of crypto trading. Inexperienced traders have been drawn to

Needham Analyst Reiterates Buy Rating on Cognex Corporation (CGNX)

Needham analyst, James Ricchiuti, reiterates his Buy rating on Cognex Corporation (NASDAQ:CGNX), and raises his price target to $55.00, following the company’s 2Q earnings report. The analyst notes that the company’s reported revenues of $147.3M, 5% above guidance of $135-140M. The analyst provides, “Excluding consumer

UBS Remains on the Sidelines For Under Armour Inc (UA) After Tough Quarter

UBS analyst Michael Binetti weighed in on Under Armour Inc (NYSE:UA) shares prior to the company’s Q2 earnings set for July 26. The analyst hopes that UA will increase its distribution network due to a tough 2Q resulting from left